|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Paclitaxel poliglumex>> Market Analysis Reports |
Market Analysis Reports of Paclitaxel poliglumex |
|
Cell Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... with aggressive NHL. OPAXIO: OPAXIO (paclitaxel poliglumex, CT-2103) is the companys biologically enhanced ... chemotherapeutic agent that links paclitaxel to a biodegradable polyglutamate ... The Novartis Intelligence Dossier International censure over Novartis’ grave delays in supplying the H1N1 vaccine. Renewed criticism by an institutional investor for CEO Daniel Vasella’s substantial pay package and considerable power. A $3.2 million US court decision against Novartis for ... |